SEC Form 8-K filed by Vascular Biogenics Ltd.
$VBLT
Biotechnology: Pharmaceutical Preparations
Health Care
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/20/2022 | Outperform → Perform | Oppenheimer | |
7/20/2022 | Buy → Neutral | H.C. Wainwright | |
7/18/2022 | $5.50 | Outperform | Oppenheimer |
4/28/2022 | $5.00 | Buy | Chardan Capital Markets |